By Sherri Oslick --
Canine EIC Genetics, LLC v. DNA Diagnostics Center, Inc.
0:12-cv-01668; filed July 11, 2012 in the District Court of Minnesota
Canine EIC Genetics, LLC v. Animal Genetics, Inc.
0:12-cv-01667; filed July 11, 2012 in the District Court of Minnesota
The complaints in these cases are substantially identical. Infringement of U.S. Patent No. 8,178,297 ("Method of Detecting Canine Exercise-Induced Collapse," issued May 15, 2012) based on defendants DNA testing services to detect whether a dog has or is predisposed to developing Canine Exercise Induced Collapse. View the DNA Diagnostics Center complaint here.
Cubist Pharmaceuticals Inc. v. Hospira Inc.
1:12-cv-00859; filed July 9, 2012 in the District Court of Delaware
Infringement of U.S. Patent No. 8,129,342 ("High Purity Lipopeptides," issued March 6, 2012) following a Paragraph IV certification as part of Hospira's filing of an ANDA to manufacture a generic version of Cubist's Cubicin® (daptomycin for injection, used for the treatment of skin infections caused by certain Gram-positive microorganisms). View the complaint here.
Endo Pharmaceuticals Inc. et al. v. TWi Pharmaceuticals Inc. et al.
1:12-cv-00848; filed July 5, 2012 in the District Court of Delaware
• Plaintiffs: Endo Pharmaceuticals Inc.; Teikoku Pharma USA Inc.; Teikoku Seiyaku Co Ltd.
• Defendants: TWi Pharmaceuticals Inc.; Teh Seng Pharmaceutical Mfg. Co. Ltd.
Infringement of U.S. Patent Nos. 5,741,510 ("Adhesive Patch for Applying Analgesic Medication to the Skin," issued April 21, 1998), 6,096,334 ("Adhesive Patch for Applying Medication to the Skin and Method," issued August 1, 2000), and 5,827,529 ("External Preparation for Application to the Skin Containing Lidocaine," issued October 27, 1998), all licensed to Endo, following a Paragraph IV certification as part of TWi's filing of an ANDA to manufacture a generic version of Endo's Lidoderm® Patch (lidocaine patch, used to treat after-shingles pain). View the complaint here.